What's in the literature?

Research output: Contribution to journalReview article

Abstract

Genetics continue to dominate the neuromuscular literature. The past 3 months have seen major breakthroughs in the genetics of amyotrophic lateral sclerosis and of Charcot-Marie-Tooth disease, perhaps paving the way for better treatments in the near future. On a hopeful note, there are several articles on treatments that may prove to be beneficial, covering such diverse disorders as chemotherapy-induced peripheral neuropathy, Duchenne muscular dystrophy, dermatomyositis, and myasthenia gravis. Useful descriptive articles appear on myofibrillar myopathies, hyperCKemia, and on myasthenia gravis associated with anti-muscle-specific tyrosine kinase antibodies, all of which provide helpful guidelines for clinicians. Finally, for those involved in electromyography, an article and an editorial address the recurring question of the risk of performing a needle examination of muscles (particularly paraspinal muscles) of patients who are taking anticoagulants or antiplatelet agents.

Original languageEnglish (US)
Pages (from-to)98-103
Number of pages6
JournalJournal of Clinical Neuromuscular Disease
Volume13
Issue number2
DOIs
StatePublished - Dec 1 2011

Fingerprint

Myasthenia Gravis
Paraspinal Muscles
Charcot-Marie-Tooth Disease
Muscles
Dermatomyositis
Duchenne Muscular Dystrophy
Platelet Aggregation Inhibitors
Amyotrophic Lateral Sclerosis
Electromyography
Peripheral Nervous System Diseases
Protein-Tyrosine Kinases
Anticoagulants
Needles
Guidelines
Drug Therapy
Antibodies
Therapeutics
Myofibrillar Myopathy

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

@article{ac58b633bec34cf6a33c81d0563ce368,
title = "What's in the literature?",
abstract = "Genetics continue to dominate the neuromuscular literature. The past 3 months have seen major breakthroughs in the genetics of amyotrophic lateral sclerosis and of Charcot-Marie-Tooth disease, perhaps paving the way for better treatments in the near future. On a hopeful note, there are several articles on treatments that may prove to be beneficial, covering such diverse disorders as chemotherapy-induced peripheral neuropathy, Duchenne muscular dystrophy, dermatomyositis, and myasthenia gravis. Useful descriptive articles appear on myofibrillar myopathies, hyperCKemia, and on myasthenia gravis associated with anti-muscle-specific tyrosine kinase antibodies, all of which provide helpful guidelines for clinicians. Finally, for those involved in electromyography, an article and an editorial address the recurring question of the risk of performing a needle examination of muscles (particularly paraspinal muscles) of patients who are taking anticoagulants or antiplatelet agents.",
author = "Zachary Simmons",
year = "2011",
month = "12",
day = "1",
doi = "10.1097/CND.0b013e31823e8247",
language = "English (US)",
volume = "13",
pages = "98--103",
journal = "Journal of Clinical Neuromuscular Disease",
issn = "1522-0443",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

What's in the literature? / Simmons, Zachary.

In: Journal of Clinical Neuromuscular Disease, Vol. 13, No. 2, 01.12.2011, p. 98-103.

Research output: Contribution to journalReview article

TY - JOUR

T1 - What's in the literature?

AU - Simmons, Zachary

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Genetics continue to dominate the neuromuscular literature. The past 3 months have seen major breakthroughs in the genetics of amyotrophic lateral sclerosis and of Charcot-Marie-Tooth disease, perhaps paving the way for better treatments in the near future. On a hopeful note, there are several articles on treatments that may prove to be beneficial, covering such diverse disorders as chemotherapy-induced peripheral neuropathy, Duchenne muscular dystrophy, dermatomyositis, and myasthenia gravis. Useful descriptive articles appear on myofibrillar myopathies, hyperCKemia, and on myasthenia gravis associated with anti-muscle-specific tyrosine kinase antibodies, all of which provide helpful guidelines for clinicians. Finally, for those involved in electromyography, an article and an editorial address the recurring question of the risk of performing a needle examination of muscles (particularly paraspinal muscles) of patients who are taking anticoagulants or antiplatelet agents.

AB - Genetics continue to dominate the neuromuscular literature. The past 3 months have seen major breakthroughs in the genetics of amyotrophic lateral sclerosis and of Charcot-Marie-Tooth disease, perhaps paving the way for better treatments in the near future. On a hopeful note, there are several articles on treatments that may prove to be beneficial, covering such diverse disorders as chemotherapy-induced peripheral neuropathy, Duchenne muscular dystrophy, dermatomyositis, and myasthenia gravis. Useful descriptive articles appear on myofibrillar myopathies, hyperCKemia, and on myasthenia gravis associated with anti-muscle-specific tyrosine kinase antibodies, all of which provide helpful guidelines for clinicians. Finally, for those involved in electromyography, an article and an editorial address the recurring question of the risk of performing a needle examination of muscles (particularly paraspinal muscles) of patients who are taking anticoagulants or antiplatelet agents.

UR - http://www.scopus.com/inward/record.url?scp=82155163823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82155163823&partnerID=8YFLogxK

U2 - 10.1097/CND.0b013e31823e8247

DO - 10.1097/CND.0b013e31823e8247

M3 - Review article

AN - SCOPUS:82155163823

VL - 13

SP - 98

EP - 103

JO - Journal of Clinical Neuromuscular Disease

JF - Journal of Clinical Neuromuscular Disease

SN - 1522-0443

IS - 2

ER -